Page 9«..891011..2030..»

Category Archives: Ulcerative Colitis

Crohn’s disease in children: Symptoms, treatment, and more – Medical News Today

Posted: Published on April 27th, 2021

Crohns disease is a type of inflammatory bowel disease (IBD) that causes chronic inflammation in the digestive tract. Continue reading

Posted in Ulcerative Colitis | Comments Off on Crohn’s disease in children: Symptoms, treatment, and more – Medical News Today

Ulcerative Colitis Treatment Market Report 2021 by Global Key Players, Types, Applications, Countries, Size, Forecast to 2027 Clark County Blog -…

Posted: Published on April 27th, 2021

The recent report on Ulcerative Colitis Treatment Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, forecast to 2027 offered by Credible Markets, comprises of a comprehensive investigation into the geographical landscape, industry size along with the revenue estimation of the business. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the Ulcerative Colitis Treatment Market. An exhaustive competition analysis that covers insightful data on industry leaders is intended to help potential market entrants and existing players in competition with the right direction to arrive at their decisions. Continue reading

Posted in Ulcerative Colitis | Comments Off on Ulcerative Colitis Treatment Market Report 2021 by Global Key Players, Types, Applications, Countries, Size, Forecast to 2027 Clark County Blog -…

Ulcerative Colitis Market Analysis with Investment Opportunity 2021: Global Opportunity and Future Trends, Business Growth Size Forecast to 2024 -…

Posted: Published on April 27th, 2021

According to the Centers for Disease Control and Prevention (CDC), in 2015, 1.3% of US adults (3 million) reported that they were diagnosed with IBD (either Crohns disease or UC). Continue reading

Posted in Ulcerative Colitis | Comments Off on Ulcerative Colitis Market Analysis with Investment Opportunity 2021: Global Opportunity and Future Trends, Business Growth Size Forecast to 2024 -…

Landos Biopharma to Present Two Late-Breaking Presentations on Therapeutic Potential of Omilancor and PX-69 at the 2021 American Association of…

Posted: Published on April 27th, 2021

BLACKSBURG, Va., April 26, 2021 (GLOBE NEWSWIRE) -- Landos Biopharma (NASDAQ: LABP), a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, today announced that two late-breaking abstracts on preclinical data of omilancor in psoriasis and proof-of concept preclinical data of PX-69 in rheumatoid arthritis will be presented at the upcoming American Association of Immunologists (AAI) Annual Meeting 2021. The meeting will be held virtually from May 10-15, 2021 Continue reading

Posted in Ulcerative Colitis | Comments Off on Landos Biopharma to Present Two Late-Breaking Presentations on Therapeutic Potential of Omilancor and PX-69 at the 2021 American Association of…

In Depth Analysis and Survey of COVID-19 Pandemic Impact on Global IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market 2021Future…

Posted: Published on April 27th, 2021

Report is a detailed study of the IBD (Ulcerative Colitis and Crohns Disease) Treatment market, which covers all the essential information required by a new market entrant as well as the existing players to gain a deeper understanding of the market.The primary objective of this research report named IBD (Ulcerative Colitis and Crohns Disease) Treatment market is to help making reliable strategic decisions regarding the opportunities in IBD (Ulcerative Colitis and Crohns Disease) Treatment market. It offers business accounts, industry investors, and industry segments with consequential insights enhancing decision making ability.[emailprotected] or call us on +1-312-376-8303 Continue reading

Posted in Ulcerative Colitis | Comments Off on In Depth Analysis and Survey of COVID-19 Pandemic Impact on Global IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market 2021Future…

‘My life revolves around going to the washroom’: COVID-19 leaves chronically ill begging for access – CBC.ca

Posted: Published on December 28th, 2020

Remo Testini says he has to use GPS to find washroom locations on his route before he leaves home each day. Continue reading

Posted in Ulcerative Colitis | Comments Off on ‘My life revolves around going to the washroom’: COVID-19 leaves chronically ill begging for access – CBC.ca

article image Op-Ed: Why an ethical code is needed for fecal microbiome therapy – Digital Journal

Posted: Published on December 28th, 2020

Direct fecal transplants (or fecal bacteriotherapy), where there is a transfer gut microbiota from healthy donors, have shown great promise in treating a range of diseases. An alternative name for the process is fecal microbiota transplant. Continue reading

Posted in Ulcerative Colitis | Comments Off on article image Op-Ed: Why an ethical code is needed for fecal microbiome therapy – Digital Journal

What major scientific breakthroughs have been made in gut microbiome science in 2020? – Gut Microbiota for Health

Posted: Published on December 28th, 2020

The COVID-19 pandemic has shifted the focus of research for scientists worldwide, probably making science nimbler once the crisis has passed. Continue reading

Posted in Ulcerative Colitis | Comments Off on What major scientific breakthroughs have been made in gut microbiome science in 2020? – Gut Microbiota for Health

No Relationship Between Recurrent C Diff and Anti-Toxin Antibodies – MD Magazine

Posted: Published on December 28th, 2020

Anti-toxin A or B antibodies were not associated with recurrent Clostridium difficile (C diff) infection, according to a paper published in the journal Anaerobe. Investigators from the University of Michigan retrospectively examined 275 adults with C diff infection in order to determine if the risk for recurrent C diff infection could be reduced if there were anti-toxin antibodies discovered in a serum sample within 48 hours of an index C diff episode. Patients admitted to Michigan Medicine between January and September 2016 were eligible for the study and the investigators studied their electronic health records, demographics, medial history, vital signs, and laboratory test results (only those conducted within 48 hours before and after C diff sample was gathered) Continue reading

Posted in Ulcerative Colitis | Comments Off on No Relationship Between Recurrent C Diff and Anti-Toxin Antibodies – MD Magazine

Best Food Deliveries for People With UC – Everyday Health

Posted: Published on December 18th, 2020

Thanks to a growing demand for convenience, the number of services that offer online meal delivery kits has exploded in recent years. Even before the COVID-19 pandemic, the number of people using meal kits grew by 36 percent from 2017 to 2018, according to Nielsen data, with another 23 percent of households saying they were open to purchasing a meal kit within six months. Meal delivery kits can be great for people who lack time to shop for food and cook, says Kelly Kennedy, a registered dietitian nutritionist with Everyday Health Continue reading

Posted in Ulcerative Colitis | Comments Off on Best Food Deliveries for People With UC – Everyday Health

Page 9«..891011..2030..»